UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 12

of 'Immunotherapy of advanced melanoma with immune checkpoint inhibition'

12
 
 
Robert C, Long GV, Schachter J, et al. Long-term outcomes in patients with ipilimumab-naïve advanced melanoma in the phase 3 KEYNOTE–006 study who completed pembrolizumab treatment (abstract 9504). 2017 American Society of Clinical Oncology annual meeting.
 
no abstract available